Back to News
Market Impact: 0.28

Are You Looking for a Top Momentum Pick? Why Elbit Systems (ESLT) is a Great Choice

ESLTNDAQ
Market Technicals & FlowsAnalyst EstimatesAnalyst InsightsCorporate EarningsCompany FundamentalsInvestor Sentiment & PositioningInfrastructure & Defense
Are You Looking for a Top Momentum Pick? Why Elbit Systems (ESLT) is a Great Choice

Elbit Systems (ESLT) registers positive momentum with a Zacks Momentum Style Score of B and a Zacks Rank #2 (Buy); shares are up 7.57% over the past week, 24.44% month-to-date, 13.79% over the past quarter and 121.17% over the last year versus the Aerospace-Defense industry and S&P 500. Twenty-day average volume is 102,069 shares, and recent analyst activity shows two upward revisions (none downward) to this year’s estimate over 60 days, lifting the consensus from $11.83 to $12.41, with one upward revision for next fiscal year—factors that support a momentum-driven buy case for investors focused on defense names.

Analysis

Market structure: Elbit (ESLT) is a direct beneficiary of renewed defense-electronics demand — +121% last 12 months and +24% last month vs. aerospace-defence industry +8% — implying rising pricing power on niche avionics/ISR systems and expanding backlog. Winners include mid-cap, export-capable electronics vendors (ESLT, smaller Israeli primes); losers are lower-tech civil aerospace suppliers and exposed commercial OEMs as capital shifts to defense. Cross-asset: continued defense risk-premium supports USD and pressures long-duration government bonds modestly (5–15 bps repricing risk if material contract expectations rise); metal/commody impacts are second-order. Risk assessment: Key tail risks are abrupt geopolitical de-escalation, export-control tightening (US/EU), or a major contract cancellation causing >10–20% EPS hit; sanctions/FCPA probes could knock 15–30% off equity. Timewise: immediate (days) risk = momentum pullback/profit-taking; short-term (weeks–months) driven by order announcements and estimate revisions; long-term (quarters–years) hinge on program wins, FCF conversion and R&D cycle. Hidden dependencies include Israeli government procurement pacing, USD/ILS moves and semiconductor supply; catalysts are upcoming FY earnings, US foreign military financing votes (30–90 days) and major DoD awards. Trade implications: Tactical direct play — establish a 2–3% long position in ESLT sized to portfolio volatility targeting +15–25% upside over 3–6 months with stop-loss at -10% or if consensus FY EPS is revised down >5%. Pair trade — long ESLT (2%) / short RTX (1.5%) to capture small-cap momentum vs. large-cap defense beta; rebalance if spread compresses >10%. Options — buy a 6‑month debit call spread (buy 25% OTM, sell 45% OTM) sized to 0.5% portfolio to cap premium and monetize upside if contract news arrives. Contrarian angles: Consensus underestimates liquidity risk — 20-day avg vol ~102k shares makes ESLT vulnerable to fast reversals; the 121% Y/Y gain raises mean-reversion risk of 20–40% if order flow disappoints. The market may be overpaying for momentum; look for entry on pullbacks to the 20‑day SMA or on a -5% intraday gap. Historical parallels (post-conflict defense rallies) show dispersion: winners were those that converted backlog to margin — monitor order-to-revenue conversion within 2–4 quarters.